share_log

Enliven Therapeutics Announces Details Regarding Presentation Of Updated ELVN-001 Phase 1a Data As ESH-iCMLf 26th Annual John Goldman Conference On CML

Enliven Therapeutics Announces Details Regarding Presentation Of Updated ELVN-001 Phase 1a Data As ESH-iCMLf 26th Annual John Goldman Conference On CML

Enliven Therapeutics宣佈有關ESH-iCMLf第26屆年度John Goldman慢性髓細胞白血病會議上ELVN-001第1a期數據更新的詳細信息。
Benzinga ·  09/19 04:06

Enliven Therapeutics Announces Details Regarding Presentation Of Updated ELVN-001 Phase 1a Data As ESH-iCMLf 26th Annual John Goldman Conference On CML

Enliven Therapeutics宣佈有關ESH-iCMLf第26屆年度John Goldman慢性髓細胞白血病會議上ELVN-001第1a期數據更新的詳細信息。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論